- Citations, last 5 years
- 2 490
- Works, last 5 years
- 440
- h-index
- 112
- Scientists listed
- 28
- Grants since 2016
- 3 213
Grants received
2017–2028 · research · R25
Tobacco Treatment Training for Cancer Care Providers
Jamie S. Ostroff · Kettering University · funded by National Institutes of Health
2017–2023 · cooperative agreement · U54
Project 2: Reversing resistance caused by lineage plasticity through epigenetic therapy
Yu Chen · Kettering University · funded by National Institutes of Health
2017–2023 · cooperative agreement · U54
Project 3: Defining the appropriate context for targeting kinase signaling in combination with androgen receptor blockade to enhance therapeutic response in metastatic prostate cancer
Brett Stewart Carver · Kettering University · funded by National Institutes of Health
2017–2023 · cooperative agreement · U54
Administative Core
Charles L. Sawyers · Kettering University · funded by National Institutes of Health
2017–2023 · cooperative agreement · U54
Project 1: Resistance caused by AR pathway reactivation
Charles L. Sawyers · Kettering University · funded by National Institutes of Health
2016–2018 · career development · K99
Immune - Microbiota Interaction in defense against Clostridium difficile
Michael C. Abt · Kettering University · funded by National Institutes of Health
2016–2019 · research · R03
Informing the Adaptation of a CHW Model to Facilitate Lung Cancer Screening for Chinese Taxi Drivers
Jennifer Cf Leng · Kettering University · funded by National Institutes of Health
2016–2020 · research · R01
Study of exposures and biomarkers in cancer epidemiology
Jaya M Satagopan · Kettering University · funded by National Institutes of Health
2016–2021 · research · R01
Mechanism and Synergy of gamma-Secretase Modulators
Yueming Li · Kettering University · funded by National Institutes of Health
2016–2020 · research · R01
Imaging drug uptake and distribution in chemoradiation therapy of pancreatic cancer
John L Humm · Kettering University · funded by National Institutes of Health
2016–2021 · research · R01
124I-NaI PET: Building block for precision medicine in metastatic thyroid cancer
John L Humm · Kettering University · funded by National Institutes of Health
2016–2021 · research · R35
Mechanism and regulation of meiotic recombination
Scott Keeney · Kettering University · funded by National Institutes of Health
2016–2021 · research · R01
Radioiodinated Multifunctional PARP1 Imaging Probes for Diagnosis and Therapy
Thomas Reiner · Kettering University · funded by National Institutes of Health
2016–2021 · research · R01
Determinants of acquired resistance in small cell lung cancer
Charles M. Rudin · Kettering University · funded by National Institutes of Health
2016–2021 · research · R01
Aberrant signaling in acute myeloid leukemia
Alex Kentsis · Kettering University · funded by National Institutes of Health
2016–2021 · research · R01
The Paradoxical Role of mTORC1 in the Growth of Nutrient-deprived Pancreatic Cancer Cells Harboring Ras Mutations
Craig B Thompson · Kettering University · funded by National Institutes of Health
2016–2023 · research · R35
Studies on oncoprotein-induced feedback: Basic and therapeutic implications
Neal Rosen · Kettering University · funded by National Institutes of Health
2016–2021 · research · R01
124I-NaI PET: Building block for precision medicine in metastatic thyroid cancer
John L Humm · Kettering University · funded by National Institutes of Health
2016–2020 · research · R01
Imaging drug uptake and distribution in chemoradiation therapy of pancreatic cancer
John L Humm · Kettering University · funded by National Institutes of Health
2016–2022 · research · R01
Developmental studies to inform clinical stratification and targeting of SHH MB
Alexandra L. Joyner · Kettering University · funded by National Institutes of Health
2016–2019 · research · R21
Exploring function of mu opioid receptor splice variants in rat by gene targeting
Ying-Xian Pan · Kettering University · funded by National Institutes of Health
2016–2021 · research · R01
Pharmacogenomic and circulating tumor cell approach to individualized treatment of pancreatic cancer
Mark Ricigliano · Kettering University · funded by National Institutes of Health
2016–2021 · research · R01
MODELING ENTERIC NERVOUS SYSTEM DEVELOPMENT AND HIRSCHSPRUNG'S DISASE IN HUMAN PLURIPOTENT STEM CELLS
Lorenz P. Studer · Kettering University · funded by National Institutes of Health
2016–2021 · research · R01
Imaging Immune Modulation in Chimeric Antigen Receptor (CAR) T Cell Therapy
Ronald George Blasberg · Kettering University · funded by National Institutes of Health
2016–2020 · research · R01
Interrogating Functions of Protein Methyltransferases with Chemical Tools
Minkui Luo · Kettering University · funded by National Institutes of Health
2016–2021 · research · R01
Aberrant signaling in acute myeloid leukemia
Alex Kentsis · Kettering University · funded by National Institutes of Health
2016–2021 · grant · DP1
3'UTR-mediated protein-protein interactions determine protein functions
Christine Mayr · Kettering University · funded by National Institutes of Health
2016–2021 · research · R01
Adaptive-Innate Immune Crosstalk in TGF-B Control of Peripheral T Cell Tolerance
Ming Li · Kettering University · funded by National Institutes of Health
2016–2020 · cooperative agreement · U01
Developing clinical, immunologic and radiographic tools to measure the clinical effect of immunotherapy in biochemically recurrent prostate cancer
James L. Gulley · Kettering University · funded by National Institutes of Health
2016–2021 · research · R01
RNA-directed targeting of AID in immunity and genomic integrity
Jayanta Chaudhuri · Kettering University · funded by National Institutes of Health
2016–2020 · research · R01
Dose-distribution radiomics to predict morbidity risk in radiotherapy
Joseph O Deasy · Kettering University · funded by National Institutes of Health
2016–2020 · research · R01
Interrogating Functions of Protein Methyltransferases with Chemical Tools
Minkui Luo · Kettering University · funded by National Institutes of Health
2016–2026 · research · R01
ABERRANT SIGNALING IN ACUTE MYELOID LEUKEMIA
Alex Kentsis · Kettering University · funded by National Institutes of Health
2016–2026 · research · R35
Mechanism and regulation of meiotic recombination
Scott Keeney · Kettering University · funded by National Institutes of Health
2016–2027 · research · R01
RNA-directed targeting of AID in immunity and cancer
Jayanta Chaudhuri · Kettering University · funded by National Institutes of Health
2016–2019 · fellowship · F31
Modeling pediatric gliomas using a human pluripotent stem cell-based platform
Ryan Christopher Smith · Kettering University · funded by National Institutes of Health
2016–2021 · research · R01
Aberrant signaling in acute myeloid leukemia
Alex Kentsis · Kettering University · funded by National Institutes of Health
2016–2021 · research · R01
Developmental studies to inform clinical stratification and targeting of SHH MB
Alexandra L. Joyner · Kettering University · funded by National Institutes of Health
2016–2021 · research · R01
KIR and HLA in cis and trans cooperatively shape human NK education
Katharine C Hsu · Kettering University · funded by National Institutes of Health
2016–2019 · fellowship · F32
Mitochondrial accumulation and counting in oogenesis via the mitochondrial UPR
Lilian Tawsein Lamech · Kettering University · funded by National Institutes of Health